About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
October 27, 2021 |
Brittany Herrick
Govt entity, and patients’ rights group oppose Covid drug patent
In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a COVID-19 pill
Related Posts
Access to Medicines
Merck’s Molnupiravir –...
Access to Medicines
Biggest Roadblock to Biden...
COVID-19
The Global Fund: A Foundat...
